BioDelivery Sciences International Inc (BDSI.OQ)
23 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|66||2012||Executive Chairman of the Board|
|63||2015||Chief Financial Officer, Treasurer, Secretary|
|2016||Vice President - Business Development|
|73||2007||Lead Independent Director|
- BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva
- BRIEF-BioDelivery Sciences Announces Launch And Availability Of Belbuca In Canada
- BRIEF-Biodelivery Sciences Announces Notice Of Allowance Of Patent Strengthening Patent Protection On Belbuca To 2032
- BRIEF-BioDelivery Sciences Reacquires Onsolis From Collegium Pharmaceutical
- BRIEF-BioDelivery Sciences Says Ohio Workers Compensation Approved Change To Formulary